Delivery Order SPE2DB20D6035-SPE2DB23FD2FR
Award Date 8/25/23
Potential Completion Date 8/28/23
Potential Value $46
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $56,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by September 21, 2023. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $56,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required by July 28, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $247 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by September 14, 2023. No set aside designation or subcontractors were identified for this...
- The Defense Logistics Agency awarded a $45,820 delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The firm fixed price order has a period of performance from August 17 to...
- The Defense Logistics Agency awarded a $46,320 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 capsules of Celecoxib 100 mg. The order was placed under an existing Prime Vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by September 27, 2023 to support the Agency's medical readiness and logistics...
- The Defense Logistics Agency awarded a $70,880 delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a one-day period from June 21 to June 22, 2023. The contract utilizes a firm fixed price structure. No...
- The Defense Logistics Agency awarded a $30,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the drug celecoxib. The order is to be fulfilled by Amerisourcebergen's Corporate Office Division facility located in Conshohocken, Pennsylvania, with work to be completed between September 8-11, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the United States Department of...
- The Defense Logistics Agency awarded a $28,140 delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a three-day period concluding on August 28, 2023. The firm fixed price order was awarded non-competitively...
- The Defense Logistics Agency awarded a $461 delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by August 9, 2023. The firm fixed price order was awarded non-competitively based on...
- The Defense Logistics Agency awarded a $64,180 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200mg Celecoxib capsules. As the prime contractor, Amerisourcebergen will provide 100 count bottles of the nonsteroidal anti-inflammatory drug to support the Department of Defense's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in July 2023. The delivery order was issued under the Defense...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB23FD2FRDelivery Order
The Defense Logistics Agency awarded a $46,350 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the prescription drug Celecoxib. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania by the end date of August 28, 2023. No set aside designation or subcontractors were identified for this order to supply the non-steroidal anti-inflammatory drug Celecoxib to DLA in support of DoD health services programs.
Generated 12/24/23, 6:26 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46 | 8/25/23 |